Trump nominates Hahn to head the US FDA
4 November 2019
President Donald Trump has nominated cancer specialist Stephen Hahn to be commissioner of the US Food and Drug Administration (FDA).
Industry News - Tag: FDA
You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
Regulatory in brief | FDA, TGA, MHRA
24 October 2019
The US Food and Drug Administration (FDA) has updated its approach to homeopathic products, Australia’s Therapeutic Goods Administration (TGA) is consulting on a proposal affecting supports supplements, and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has announced a promotion...
Regulators worldwide take action on ranitidine
Premium
27 September 2019
Regulatory agencies around the world are taking action on medicines containing ranitidine after tests showed some contain "low levels" of a probable human carcinogen called N-nitrosodimethylamine (NDMA).
FDA advisers back GSK's OTC nicotine oral spray
Premium
23 September 2019
Advisers to the US Food and Drug Administration (FDA) have recommended that GlaxoSmithKline (GSK) Consumer Healthcare's nicotine oral spray can be marketed as an OTC product.
GSK seeks OTC status for nicotine oral spray in US
Premium
20 August 2019
GlaxoSmithKline (GSK) Consumer Healthcare is seeking to extend its range of OTC nicotine-replacement therapy (NRT) products in the US with a nicotine oral spray.
Sanofi snaps up OTC rights to Tamiflu in US
Premium
23 July 2019
Sanofi has gained exclusive OTC rights to Roche's Tamiflu (oseltamivir) for prevention and treatment of flu in the US.
People in Brief | Alliance Pharma, Pfizer, BAH
1 July 2019
Alliance Pharma, Pfizer and the German Medicines Manufacturers' Association, the BAH, have all recently announced people changes.
Regulators must move quickly on CBD regulation
Premium
7 June 2019
The US Food and Drug Administration (FDA) needs to "step up very quickly" with regulation for cannabidiol (CBD) products, says Scott Melville, president and chief executive officer of the US Consumer Healthcare Products Association (CHPA). According to Melville, the current situation in the US is li...
US FDA considers ways of regulating CBD
9 April 2019
The US Food and Drug Administration (FDA) is holding a public hearing on potential ways of regulating products containing cannabis and cannabis-derived compounds including cannabidiol (CBD).
Scott Gottlieb resigns as FDA commissioner
5 March 2019
Scott Gottlieb has resigned as commissioner of the US Food and Drug Administration (FDA) just two years after he was appointed to the post.